You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

New therapies in systemic lupus erythematosus—trials,troubles and tribulations—working towards a solution: part 2—the politically incorrect version

Lupus

Impact Factor: 1.9 / 5-Year Impact Factor: 2.3

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online February, 2009

New therapies in systemic lupus erythematosus—trials,troubles and tribulations—working towards a solution: part 2—the politically incorrect version

Volume 18, Issue 2

https://doi.org/10.1177/0961203308100843

Abstract

Get full access to this article

View all access options for this article.

References

2 Isenberg D Gordon C Merrill J Urowitz M . New therapies in systemic lupus erythematosus – trials, troubles and tribulations…working towards a solution. Lupus 2008; 17: 967–970 [editorial].

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus

Retricted access

A New Synthetic Protease Inhibitor,E-3123,Prevents Lysosomal and Mitochondrial Fragility in Rat Caerulein-Induced Pancreatitis

Retricted access

Are DNA antibodies actually pathogenic?

Retricted access

Pathophysiologic and Endocrine Aspects